Boston Scientific Corp
BSX· NYSE
BSXBoston Scientific Corp
Source filing unavailable
| Metric | Q1 2011 | Q1 2010 | Q1 2009 |
|---|---|---|---|
| Revenue | $1.93B | $1.96B | $2.01B |
| Net Income | $46.00M | -$1.59B | -$13.00M |
| EPS Diluted | $0.03 | -$1.05 | -$0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Boston Scientific Corp · CIK 885725 · Engraved from SEC EDGAR
